LIANG S[au] - Search Results

Year	Number of Results
1947	1
1948	1
1957	2
1958	4
1959	2
1960	1
1963	2
1970	1
1973	1
1976	2
1977	3
1979	2
1980	6
1981	5
1982	5
1983	6
1984	7
1985	15
1986	12
1987	12
1988	13
1989	11
1990	12
1991	13
1992	17
1993	22
1994	19
1995	19
1996	13
1997	27
1998	22
1999	32
2000	42
2001	43
2002	55
2003	60
2004	70
2005	84
2006	106
2007	135
2008	190
2009	178
2010	212
2011	252
2012	304
2013	366
2014	437
2015	436
2016	481
2017	509
2018	622
2019	729
2020	866
2021	968
2022	576

1

Macrophage NFATc3 prevents foam cell formation and atherosclerosis: evidence and mechanisms.

Liu X, Guo JW, Lin XC, Tuo YH, Peng WL, He SY, Li ZQ, Ye YC, Yu J, Zhang FR, Ma MM, Shang JY, Lv XF, Zhou AD, Ouyang Y, Wang C, Pang RP, Sun JX, Ou JS, Zhou JG, Liang SJ. Liu X, et al. Among authors: liang sj. Eur Heart J. 2021 Dec 14;42(47):4847-4861. doi: 10.1093/eurheartj/ehab660. Eur Heart J. 2021. PMID: 34570211

2

A PLCB1-PI3K-AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression.

Liang S, Guo H, Ma K, Li X, Wu D, Wang Y, Wang W, Zhang S, Cui Y, Liu Y, Sun L, Zhang B, Xin M, Zhang N, Zhou H, Liu Y, Wang J, Liu L. Liang S, et al. Cancer Res. 2021 Dec 1;81(23):5889-5903. doi: 10.1158/0008-5472.CAN-21-1538. Epub 2021 Sep 27. Cancer Res. 2021. PMID: 34580062

3

miR-663b promotes tumor cell proliferation, migration and invasion in nasopharyngeal carcinoma through targeting TUSC2.

Liang S, Zhang N, Deng Y, Chen L, Zhang Y, Zheng Z, Luo W, Lv Z, Li S, Xu T. Liang S, et al. Exp Ther Med. 2021 Dec;22(6):1448. doi: 10.3892/etm.2021.10883. Epub 2021 Oct 14. Exp Ther Med. 2021. PMID: 34721690 Free PMC article.

4

Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation.

Long B, Carius BM, Chavez S, Liang SY, Brady WJ, Koyfman A, Gottlieb M. Long B, et al. Among authors: liang sy. Am J Emerg Med. 2022 Apr;54:46-57. doi: 10.1016/j.ajem.2022.01.028. Epub 2022 Jan 21. Am J Emerg Med. 2022. PMID: 35121478 Free PMC article. Review.

5

Remdesivir treatment in hospitalized patients with COVID-19: a comparative analysis of in-hospital all-cause mortality in a large multi-center observational cohort.

Mozaffari E, Chandak A, Zhang Z, Liang S, Thrun M, Gottlieb RL, Kuritzkes DR, Sax PE, Wohl DA, Casciano R, Hodgkins P, Haubrich R. Mozaffari E, et al. Among authors: liang s. Clin Infect Dis. 2021 Oct 1:ciab875. doi: 10.1093/cid/ciab875. Online ahead of print. Clin Infect Dis. 2021. PMID: 34596223

6

[Retracted] miR‑663 promotes NPC cell proliferation by directly targeting CDKN2A.

Liang S, Zhang N, Deng Y, Chen L, Zhang Y, Zheng Z, Luo W, Lv Z, Li S, Xu T. Liang S, et al. Mol Med Rep. 2022 Jan;25(1):23. doi: 10.3892/mmr.2021.12539. Epub 2021 Nov 23. Mol Med Rep. 2022. PMID: 34812473 Free PMC article.

7

Mitolysosome exocytosis, a mitophagy-independent mitochondrial quality control in flunarizine-induced parkinsonism-like symptoms.

Bao F, Zhou L, Zhou R, Huang Q, Chen J, Zeng S, Wu Y, Yang L, Qian S, Wang M, He X, Liang S, Qi J, Xiang G, Long Q, Guo J, Ying Z, Zhou Y, Zhao Q, Zhang J, Zhang D, Sun W, Gao M, Wu H, Zhao Y, Nie J, Li M, Chen Q, Chen J, Zhang X, Pan G, Zhang H, Li M, Tian M, Liu X. Bao F, et al. Among authors: liang s. Sci Adv. 2022 Apr 15;8(15):eabk2376. doi: 10.1126/sciadv.abk2376. Epub 2022 Apr 13. Sci Adv. 2022. PMID: 35417232 Free PMC article.

8

Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19.

Bi X, Liu W, Ding X, Liang S, Zheng Y, Zhu X, Quan S, Yi X, Xiang N, Du J, Lyu H, Yu D, Zhang C, Xu L, Ge W, Zhan X, He J, Xiong Z, Zhang S, Li Y, Xu P, Zhu G, Wang D, Zhu H, Chen S, Li J, Zhao H, Zhu Y, Liu H, Xu J, Shen B, Guo T. Bi X, et al. Among authors: liang s. Cell Rep. 2022 Jan 18;38(3):110271. doi: 10.1016/j.celrep.2021.110271. Epub 2021 Dec 28. Cell Rep. 2022. PMID: 35026155 Free PMC article.

9

Hierarchical Ni₃S₂nanorod@nanosheet arrays on Ni foam for high-performance supercapacitor.

Sun H, Liang S, Xu Z, Zheng W, Liu X, Zhang C, Gao S, Ji Z, Liu S, Xie W. Sun H, et al. Among authors: liang s. Nanotechnology. 2021 Nov 25;33(7). doi: 10.1088/1361-6528/ac37e1. Nanotechnology. 2021. PMID: 34753121

10

A split prime editor with untethered reverse transcriptase and circular RNA template.

Liu B, Dong X, Cheng H, Zheng C, Chen Z, Rodríguez TC, Liang SQ, Xue W, Sontheimer EJ. Liu B, et al. Among authors: liang sq. Nat Biotechnol. 2022 Apr 4. doi: 10.1038/s41587-022-01255-9. Online ahead of print. Nat Biotechnol. 2022. PMID: 35379962

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results